Related Experiment Video
Updated: Aug 24, 2025
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.8K
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation.
Renee Wu1, Ray A Ohara1, Suin Jo1
1Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
Nature Immunology
|October 21, 2022
Summary
CD40 signaling in dendritic cells is crucial for anti-tumor immunity by promoting CD8 T cell responses. It also enhances dendritic cell survival through Bcl2l1, supporting effective anti-tumor immunity.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Background:
- CD40 signaling in classical type 1 dendritic cells (cDC1s) is essential for CD8 T cell-mediated tumor rejection.
- The precise mechanisms by which CD40 signaling promotes anti-tumor immunity remain incompletely understood.
Purpose of the Study:
- To identify CD40-induced genes in cDC1s and elucidate their roles in anti-tumor immunity.
- To investigate the contribution of CD40 signaling to cDC1 survival and function during anti-tumor responses.
Main Methods:
- Identification of CD40-induced genes in cDC1s (e.g., Cd70, Tnfsf9, Ptgs2, Bcl2l1).
- Assessment of anti-tumor immunity following cDC1-specific gene inactivation or global gene inactivation.
- Analysis of cDC1 mitochondrial function, caspase activation, and migratory capacity.
- In vitro antigen presentation assays with modified cDC1s.
Main Results:
- Inactivation of CD70, COX-2, or CD27 partially impaired tumor rejection and CD8 T cell expansion.
- CD40 inactivation in cDC1s reduced mitochondrial potential, increased caspase activation, and decreased cDC1 migration.
- Impaired in vitro antigen presentation by CD40-deficient cDC1s was rescued by Bcl2l1 re-expression.
- CD40 signaling induces both costimulatory ligands and Bcl2l1 for cDC1 survival.
Conclusions:
- CD40 signaling in cDC1s is vital for anti-tumor immunity, acting through both T cell costimulatory ligands and enhanced cDC1 survival.
- Bcl2l1 induction by CD40 signaling plays a critical role in maintaining cDC1 viability during the priming of anti-tumor CD8 T cell responses.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
3.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
3.0K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
01:20The JAK-STAT Signaling Pathway
9.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.1K
01:19Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
02:39Positive Regulator Molecules
5.6K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K